Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.
Sling Therapeutics has raised $35.0M in total funding. The most recent round was Series A. The last funding was announced in June 2022.
Sling Therapeutics's investors include The Rise Fund.
Sling Therapeutics is headquartered in Ann Arbor, United States.
Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease.
Sling Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sling Therapeutics — Funding & Investors." VCBacked, June 13, 2022, https://www.vcbacked.co/company/sling-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Sling Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sling-therapeutics
{{cite web |title=Sling Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sling-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated